scholarly journals Anxiety in patients with permanent cardiac pacemaker aged > 60 years old

2020 ◽  
Vol 6 (2) ◽  
pp. 66
Author(s):  
Stella Vasileiou ◽  
Moschoula Mina Iordani ◽  
Illias Martinis ◽  
Alexandra Nikitopoulou ◽  
Jona Sakiqi ◽  
...  

Introduction: A cardiac pacemaker is a small implanted device to control abnormal heart rhythms. According to estimates, 3 million individuals worldwide live with an implanted permanent pacemaker (PPM) while about 600 thousand pacemakers are implanted, annually.Purpose: to explore anxiety of pacemaker recipients as well as all the associated demographic and self-reported characteristics.Material and Method: 100 outpatients with PPM were enrolled in the study. Collection of data was performed by the completion of the “Self-rating Anxiety Scale Zung (SAS)” which included patients' characteristics.  Results: From the 100 participants 65% were men, 66% were >70 years old, 60% married, 50,5% of primary education and 90% lived in Attica. In terms of anxiety, 50% of recipients scored less than 48 on SAS scale (wide of range: 20-80) indicating mild to low levels of anxiety. Regarding associated factors, anxiety was found to be statistically significantly associated with gender (p=<0,001), understanding of provided information (p=<0,001), understanding of precautions in electromagnetic fields (p=0,021), desire for more frequent and long term follow-up and devise assessment (p=<0,001 and p=<0,001, respectively).Conclusions: Though pacemaker is an opportunity to prolong survival, however systematic assessment of anxiety and all the associated factors is considered to be of primary importance in clinical pacemaker settings.

2018 ◽  
Vol 44 (10) ◽  
pp. 1323-1331 ◽  
Author(s):  
Anne-Christine Walter ◽  
Markus Meissner ◽  
Roland Kaufmann ◽  
Eva Valesky ◽  
Andreas Pinter

2015 ◽  
Vol 159 (1) ◽  
pp. 160-168.e2 ◽  
Author(s):  
Ko Eun Kim ◽  
Jin Wook Jeoung ◽  
Dong Myung Kim ◽  
Seong Joon Ahn ◽  
Ki Ho Park ◽  
...  

2015 ◽  
Vol 57 (4) ◽  
pp. 408
Author(s):  
Turgay Celik ◽  
Esra Goktas ◽  
Hasan Kabul ◽  
Sevket Balta ◽  
Atila Iyisoy ◽  
...  

2009 ◽  
Vol 32 (1) ◽  
pp. 7-12 ◽  
Author(s):  
OFER MERIN ◽  
MICHAEL ILAN ◽  
AVRAHAM OREN ◽  
DANIEL FINK ◽  
MAHER DEEB ◽  
...  

EP Europace ◽  
2005 ◽  
Vol 7 (Supplement_1) ◽  
pp. 5-6
Author(s):  
O. Merin ◽  
M. Ilan ◽  
D. Fink ◽  
A. Oren ◽  
M. Deeb ◽  
...  

1982 ◽  
Vol 103 (3) ◽  
pp. 332-337 ◽  
Author(s):  
Dennis C. Besley ◽  
Gregory J. McWilliams ◽  
Douglas S. Moodie ◽  
Lon W. Castle

EP Europace ◽  
2021 ◽  
Vol 23 (Supplement_3) ◽  
Author(s):  
L Tua ◽  
A Turco ◽  
M Acquaro ◽  
L Scelsi ◽  
A Greco ◽  
...  

Abstract Funding Acknowledgements Type of funding sources: None. Background and purpose Permanent pacemaker implantation (PPMi) is needed in about 5% of patients following heart transplant (HTx) primarily due to sinus node dysfunction (SND), which commonly occurs in an early phase, or to atrio-ventricular block (ABV), which is common later on. Currently, data on rate of ventricular pacing (VP) is lacking and little is known on long-term outcomes after PPMi. Methods This was a retrospective, monocentric study. Among 1123 patients treated with HTx, all with biatrial technique, from november 1985 to march 2019 at our institution, 61 (5.4%) patients needed PPMi. PM parameters, clinical and echocardiographic data were collected at 1 month and at 1-3-5-10 years follow-up. The primary aim was to analyse the percentage of right ventricular pacing in the overall population and in subgroups stratified by the timing of PPMi and by pacing indication. Secondary endpoints were to analyze long-term outcomes according to the percentage of ventricular pacing and to the type of implanted PM (single vs. dual chamber).  Results Among patients treated with PPMi (68.9% single-chamber), 62.2% were implanted for SND and 36% for AVB. Early PPMi (&lt; 3 months after HTx), occurred in 34.4% of patients, mainly due to SND, while late PPMi (&gt; 3 months after HTx) occurred in 65,6% with an equal distribution between SND and AVB. Median follow-up time from HTx was 140 months and 82 months from PPMi. Overall mean rate of VP was 21%. Rate of VP was higher in patients implanted early rather than late after HTx, both at 1 month (91% vs 2%, P = 0,002) and at 1 year after the procedure (43 vs 1, P = 0,037). Patients with AVB had a greater rate of VP compared to those implanted for SND, irrespective of timing of implantation and these findings were still present at 3 and 5 years follow-up (62 vs 1%, P = 0,011 at 3 years and 80 vs 6%, P = 0,002 at 5 years). VP declined progressively after PPM implantation. No differences were observed in terms of 10-years mortality between early vs late PPMi, dual vs single-chamber and mean VP &gt; 21% vs ≤ 21%. Conclusions Patients treated with PPMi after HTx show on average low percentage of VP over long-term follow-up. AV block indication and early implantation are associated with a higher percentage of VP. The rate of VP, the timing of PPMi and the use of single vs dual chamber PM do not affect overall prognosis or left ventricular systolic function. Our data may justify implantation of a single-chamber PPM, which bears less complications and procedural time, in the majority of HTx patients needing PPMi.


Sign in / Sign up

Export Citation Format

Share Document